Intercept Pharmaceuticals, Inc...

NASDAQ: ICPT
$10.48
-$0.32 (-3.0%)
Closing price September 22, 2023

Top Analyst Upgrades and Downgrades: Abbott Labs, AMD, Analog Devices, Applied Materials, Ford, Illumina, Medtronic, Tesla, Wells Fargo and More
Top analyst upgrades, downgrades and initiations for the first trading day of 2020 included Abbott Laboratories, Advanced Micro Devices, Analog Devices, Applied Materials, Ford, Illumina, Medtronic,...
Jon C. Ogg
3 years ago
Last Updated: 3 years ago

The Top Biopharma Calendar Events to Watch Going Into 2020
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Chris Lange
3 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: Caesars, Chipotle, Host Hotels, Kellogg, McDonald's, Shopify, Starbucks, Tiffany and More
The top analyst upgrades, downgrades and initiations on Tuesday included Caesars, Chipotle Mexican Grill, Host Hotels, Kellogg, McDonald's, Shopify, Starbucks and Tiffany.
Lee Jackson
4 years ago
Last Updated: 3 years ago

How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double
Intercept Pharmaceuticals was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall...
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment
Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic...
Chris Lange
4 years ago
Last Updated: 3 years ago

Why Gilead's Pain Is Intercept's Gain
It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for Intercept Pharmaceuticals.
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: BHP, Cisco, Crown Castle, Gilead, Goldcorp, Take-Two, Varonis, Whiting Petroleum and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included BHP, Cisco Systems, Crown Castle, Gilead Sciences, Goldcorp, Take-Two Interactive Software, Varonis Systems and Whiting...
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: AON, Conoco, Groupon, JinkoSolar, NextEra, WisdomTree, Xilinx, Yelp and More
The top analyst upgrades, downgrades and initiations seen om Monday included AON, Conoco, Groupon, Intuit, JinkoSolar, NextEra, WisdomTree, Xilinx and Yelp.
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More
The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell, ServiceNow and Tiffany.
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Apple, Carnival, Ciena, Juniper Networks, Lockheed Martin, Plug Power, Take-Two Interactive Software, United...
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More
  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see numerous waves of selling in...
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Top Analyst Upgrades and Downgrades: Boston Scientific, Etsy, GE, Morgan Stanley, SeaWorld, Skechers, Shopify, Square, Tesla and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included Boston Scientific, Etsy, General Electric, Morgan Stanley, SeaWorld, Skechers, Shopify, Square and Tesla.
Jon C. Ogg
4 years ago
Last Updated: 3 years ago

Even More Biopharma Catalysts Coming Through the End of March
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Chris Lange
5 years ago
Last Updated: 3 years ago

Merrill Lynch's Top Biotech Acquisition Targets in 2018
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Chris Lange
5 years ago
Last Updated: 3 years ago

Major Biopharma Catalysts and FDA Events to Look For in March
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Chris Lange
5 years ago
Last Updated: 3 years ago